Review: Mycobacterium leprae – millennium resistant! Leprosy control on the threshold of a new era
- 1 June 2000
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 5 (6) , 388-399
- https://doi.org/10.1046/j.1365-3156.2000.00572.x
Abstract
Summary Over the past decades, the conditions of leprosy control implementation have changed dramatically. Introduction of multidrug therapy, together with the global effort of the World Health Organization to eliminate leprosy as a public health problem, had a tremendous impact on leprosy control, particularly by decreasing the registered prevalence of the disease. At the beginning of the new millennium, leprosy control programmes face several new challenges. These relate not only to changes in the prevalence of the disease, but also to changes in the context of leprosy control, such as those created by health sector reforms and other disease control programmes. This review discusses current knowledge on the epidemiology of Mycobacterium leprae and some important aspects of leprosy control. It is argued that our understanding is still insufficient and that, so far, no consistent evidence exists that the transmission of leprosy has been substantially reduced. Sustainable leprosy control, rather than elimination, should be our goal for the foreseeable future, which also includes care for patients on treatment and for those released from treatment. This, however, requires new strategies.Keywords
This publication has 22 references indexed in Scilit:
- Is it safe to shorten multidrug therapy for lepromatous (LL and BL) leprosy to 12 months?Leprosy Review, 1998
- Leprosy transmission and mucosal immunity: towards eradication?Leprosy Review, 1998
- Leprosy beyond the year 2000The Lancet, 1997
- Leprosy and tuberculosis: the epidemiological consequences of cross-immunity.American Journal of Public Health, 1997
- The epidemiology of Mycobacterium leprae: Recent insightFEMS Microbiology Letters, 1996
- Variation in protection by BCG: implications of and for heterologous immunityThe Lancet, 1995
- Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in IndonesiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- LEPROSY AND COMMUNITY - BASED REHABILITATIONLeprosy Review, 1995
- HIV infection and leprosy: a four-year survey in EthiopiaThe Lancet, 1994
- Relapses after multidrug therapy for leprosy: a preliminary report of 22 cases in West NepalLeprosy Review, 1989